Company intelligence / Profile preview
Shandong Kangzhonghong Pharmaceutical Technology Development
Shandong Sheng, Chinakzyy88.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Shandong Kangzhonghong Pharmaceutical Technology Development is a private Chinese pharmaceutical company focused on the development of herbal medicines for infectious diseases, immune system diseases, and respiratory diseases. Its lead programs include Bimin Capsule (for perennial allergic rhinitis), Kemin Capsule (for cough), both in Phase 3 trials, and Xiao'er Qingzhen Oral Liquid (for hand, foot and mouth disease) in Phase 2[4]. The company has at least four herbal drug candidates in its pipeline.
- Therapeutic areas
- PulmonologyImmunologyInfectious Diseases
- Modalities
- Herbal medicine
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Shandong Kangzhonghong Pharmaceutical Technology Development.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shandong Kangzhonghong Pharmaceutical Technology Development.